So my understanding here, from evaluating yourself and left-e, could be that this announcement in a way is a good thing, because at least the FDA are giving due consideration to a very serious illness that affects many, including children. So a prophylactic is a preventative to GVDH not a treatment once acquired, like Rem-L is? Again, this is like a covid vaccine against our treatment of severe ARDS being Rem-L, and so completely different, but ours probably more important at the saving from mortality end? Have I interpreted this correctly?
Cell Therapy News/Articles, page-10733
-
- There are more pages in this discussion • 7,138 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42268 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 48002 | 3 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |